Check out all the latest news from SENS Research Foundation in our February newsletter. You might also like to check out the archive of past messages, or subscribe to our mailing list to make sure you don't miss out on future updates!

In response to the many requests SENS Research Foundation has received from supporters, we are now able to accept donations of Bitcoin.

January 7, 2014: The SENS Research Foundation announced today that applications are open for the 2015 SRF Summer Scholars Program.

We're delighted to announce that both of our 2014 year-end challenge grants, organised by Fight Aging! and Ronny Hatteland, were fully met thanks to your generous donations - releasing $110,000 in additional funding for our research.

Independent global biotech news and stock analysts BioWatch News published a special edition of their monthly report reviewing the Rejuvenation Biotechnology Conference 2014, including interviews with the organisers and a wealth of investor-targeted information and commentary.

SENS Research Foundation-funded PhD candidate David Brindley, and Summer Scholar James Smith, present the first of several blogs about the Rejuvenation Biotechnology Conference for the Canadian Centre for the Commercialisation of Regenerative Medicine.

Theral Timpson reviews the Rejuvenation Biotechnology 2014 conference from a delegate's perspective, highlighting the keynote speakers and praising the event's in-depth focus on specific biomedical and social/regulatory challenges.

SRF sponsored fifteen student researchers at six different institutions during the 2014 SRF Summer Scholars Program. Learn more about their experiences and their research through SRF Education’s series of video profiles.

The application for the 2015 SRF Summer Scholars Program is now available. Paid undergraduate research positions are available at nine prestigious institutions located in the US and the UK. Submit an online application by February 2, 2015.

SENS Research Foundation CEO Mike Kope introduces the Rejuvenation Biotechnology conference, discussing the worldwide burden of age-related disease and the urgent need for a paradigm shift in understanding and treating such conditions.

David Brindley and James Smith consider the provocative question: if I gave you the option to take a drug offering a 100 percent chance of survival to average life expectancy at which time you would certainly fall down dead, would you take it?

The Rejuvenation Biotechnology conference was more than an academic event, featuring major contributions from investors, policymakers and regulators. This article discusses the cross-disciplinary potential arising from such a meeting of minds.

Drawing on material from Rejuvenation Biotechnology 2014 presentations by Peter Diamandis and Bob Clay, David Brindley and James Smith discuss the concept and potential of exponential change in the context of cell therapy.

SENS Research Foundation is delighted to release our 2014 Annual Report, containing detailed updates on all of our current research, outreach, and educational programs, plus a summary of our 2013 finances.

SENS Research Foundation is delighted to sponsor the World Stem Cell Summit 2014, an event covering interdisciplinary biomedical research, law, business and ethics. SRF CSO Dr. de Grey will chair a session this year as part of his fifth consecutive WSCS appearance.

SRF-funded Oxford University PhD student David Brindley's paper, "The Global Intellectual Property Landscape of Induced Pluripotent Stem Cell Technologies", was published in the August issue of Nature Biotechnology.

Check out all the latest news from SENS Research Foundation in our February newsletter. You might also like to check out the archive of past messages, or subscribe to our mailing list to make sure you don't miss out on future updates!

In response to the many requests SENS Research Foundation has received from supporters, we are now able to accept donations of Bitcoin.

January 7, 2014: The SENS Research Foundation announced today that applications are open for the 2015 SRF Summer Scholars Program.

We're delighted to announce that both of our 2014 year-end challenge grants, organised by Fight Aging! and Ronny Hatteland, were fully met thanks to your generous donations - releasing $110,000 in additional funding for our research.

Independent global biotech news and stock analysts BioWatch News published a special edition of their monthly report reviewing the Rejuvenation Biotechnology Conference 2014, including interviews with the organisers and a wealth of investor-targeted information and commentary.

SENS Research Foundation-funded PhD candidate David Brindley, and Summer Scholar James Smith, present the first of several blogs about the Rejuvenation Biotechnology Conference for the Canadian Centre for the Commercialisation of Regenerative Medicine.

Theral Timpson reviews the Rejuvenation Biotechnology 2014 conference from a delegate's perspective, highlighting the keynote speakers and praising the event's in-depth focus on specific biomedical and social/regulatory challenges.

SRF sponsored fifteen student researchers at six different institutions during the 2014 SRF Summer Scholars Program. Learn more about their experiences and their research through SRF Education’s series of video profiles.

The application for the 2015 SRF Summer Scholars Program is now available. Paid undergraduate research positions are available at nine prestigious institutions located in the US and the UK. Submit an online application by February 2, 2015.

SENS Research Foundation CEO Mike Kope introduces the Rejuvenation Biotechnology conference, discussing the worldwide burden of age-related disease and the urgent need for a paradigm shift in understanding and treating such conditions.

David Brindley and James Smith consider the provocative question: if I gave you the option to take a drug offering a 100 percent chance of survival to average life expectancy at which time you would certainly fall down dead, would you take it?

The Rejuvenation Biotechnology conference was more than an academic event, featuring major contributions from investors, policymakers and regulators. This article discusses the cross-disciplinary potential arising from such a meeting of minds.

Drawing on material from Rejuvenation Biotechnology 2014 presentations by Peter Diamandis and Bob Clay, David Brindley and James Smith discuss the concept and potential of exponential change in the context of cell therapy.

SENS Research Foundation is delighted to release our 2014 Annual Report, containing detailed updates on all of our current research, outreach, and educational programs, plus a summary of our 2013 finances.

SENS Research Foundation is delighted to sponsor the World Stem Cell Summit 2014, an event covering interdisciplinary biomedical research, law, business and ethics. SRF CSO Dr. de Grey will chair a session this year as part of his fifth consecutive WSCS appearance.

SRF-funded Oxford University PhD student David Brindley's paper, "The Global Intellectual Property Landscape of Induced Pluripotent Stem Cell Technologies", was published in the August issue of Nature Biotechnology.

Check out all the latest news from SENS Research Foundation in our February newsletter. You might also like to check out the archive of past messages, or subscribe to our mailing list to make sure you don't miss out on future updates!

In response to the many requests SENS Research Foundation has received from supporters, we are now able to accept donations of Bitcoin.

January 7, 2014: The SENS Research Foundation announced today that applications are open for the 2015 SRF Summer Scholars Program.

We're delighted to announce that both of our 2014 year-end challenge grants, organised by Fight Aging! and Ronny Hatteland, were fully met thanks to your generous donations - releasing $110,000 in additional funding for our research.

Independent global biotech news and stock analysts BioWatch News published a special edition of their monthly report reviewing the Rejuvenation Biotechnology Conference 2014, including interviews with the organisers and a wealth of investor-targeted information and commentary.

SENS Research Foundation-funded PhD candidate David Brindley, and Summer Scholar James Smith, present the first of several blogs about the Rejuvenation Biotechnology Conference for the Canadian Centre for the Commercialisation of Regenerative Medicine.

Theral Timpson reviews the Rejuvenation Biotechnology 2014 conference from a delegate's perspective, highlighting the keynote speakers and praising the event's in-depth focus on specific biomedical and social/regulatory challenges.

SRF sponsored fifteen student researchers at six different institutions during the 2014 SRF Summer Scholars Program. Learn more about their experiences and their research through SRF Education’s series of video profiles.

The application for the 2015 SRF Summer Scholars Program is now available. Paid undergraduate research positions are available at nine prestigious institutions located in the US and the UK. Submit an online application by February 2, 2015.

SENS Research Foundation CEO Mike Kope introduces the Rejuvenation Biotechnology conference, discussing the worldwide burden of age-related disease and the urgent need for a paradigm shift in understanding and treating such conditions.

David Brindley and James Smith consider the provocative question: if I gave you the option to take a drug offering a 100 percent chance of survival to average life expectancy at which time you would certainly fall down dead, would you take it?

The Rejuvenation Biotechnology conference was more than an academic event, featuring major contributions from investors, policymakers and regulators. This article discusses the cross-disciplinary potential arising from such a meeting of minds.

Drawing on material from Rejuvenation Biotechnology 2014 presentations by Peter Diamandis and Bob Clay, David Brindley and James Smith discuss the concept and potential of exponential change in the context of cell therapy.

SENS Research Foundation is delighted to release our 2014 Annual Report, containing detailed updates on all of our current research, outreach, and educational programs, plus a summary of our 2013 finances.

SENS Research Foundation is delighted to sponsor the World Stem Cell Summit 2014, an event covering interdisciplinary biomedical research, law, business and ethics. SRF CSO Dr. de Grey will chair a session this year as part of his fifth consecutive WSCS appearance.

SRF-funded Oxford University PhD student David Brindley's paper, "The Global Intellectual Property Landscape of Induced Pluripotent Stem Cell Technologies", was published in the August issue of Nature Biotechnology.